PlainRecalls
FDA Drug Moderate Class II Terminated

Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31

Reported: November 28, 2018 Initiated: November 7, 2018 #D-0283-2019

Product Description

Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31

Reason for Recall

Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.

Details

Units Affected
4,212 (30-count blister pack)
Distribution
U.S.A.nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 4,212 (30-count blister pack).
Why was this product recalled?
Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 28, 2018. Severity: Moderate. Recall number: D-0283-2019.